Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AIDS Causes Brain Damage

By HospiMedica staff writers
Posted on 02 Nov 2005
For the first time, new imaging research demonstrates the selective pattern of injury inflicted by AIDS on brain areas that regulate motor, language, and sensory functions. More...
High-resolution three-dimensional (3D) color scans created from magnetic resonance images (MRI) brilliantly illustrate the damage.

The study, performed by scientists from the University of California, Los Angeles (UCLA, USA) and the University of Pittsburgh (PA, USA), was published October 10, 2005, on the online website of the Proceedings of the [U.S.] National Academy of Sciences. The study presented a new method to measure the impact of AIDS on the living brain, and reveals that the brain is still susceptible to infection when patients are receiving highly active antiretroviral therapy (HAART).

"Two big surprises came out of this study,” explained Paul Thompson, Ph.D., first author and associate professor of neurology at the David Geffen School of Medicine at UCLA. "First, that AIDS is selective in how it attacks the brain. Second, drug therapy does not appear to slow the damage. The brain provides a sanctuary for HIV where most drugs cannot follow.”

Dr. Thompson's laboratory utilized a new 3D brain-mapping technique developed at UCLA to analyze the MRI scans of 26 people diagnosed with AIDS, and then compared the scans to those of 14 HIV-negative people. The brain scans measured the thickness of gray matter in various regions of the cerebral cortex. Scientists diagnosed and scanned the AIDS patients; all 26 individuals had lost at least half of their T-cells, the immune cells targeted by HIV. None had experienced AIDS-related dementia, and 13 were on HAART.

The striking differences between the AIDS patients' and the control individuals' brain scans were easy to see on the detailed 3D images. Regions of tissue loss shone red and yellow, whereas intact areas glowed blue and green. The researchers were also surprised to discover that AIDS consistently injured the brain's motor, judgment, and language centers, but left other areas alone. Specific patterns of tissue damage directly correlated with patients' mental and physical symptoms, including impaired motor coordination and slowed reflexes.

The UCLA group also tied thinning of the language cortex and reasoning center to depletion of T-cells from the immune system. This discovery may provide insights into why AIDS is often accompanied by mild vocabulary loss, judgment problems, and difficulty planning. As the disease progresses, these symptoms can deteriorate into memory loss and dementia similar to Alzheimer's disease.




Related Links:
University of California, Los Angeles
University of Pittsburgh

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.